Alaunos Therapeutics, Inc. (TCRT)
1.50
-0.06
(-3.85%)
USD |
NASDAQ |
Sep 10, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Alaunos Therapeutics Market Cap : 3.729M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 3.878M |
| September 08, 2026 | 3.903M |
| September 04, 2026 | 4.052M |
| September 03, 2026 | 4.102M |
| September 02, 2026 | 4.152M |
| September 01, 2026 | 4.127M |
| August 31, 2026 | 4.226M |
| August 28, 2026 | 3.990M |
| August 27, 2026 | 4.127M |
| August 26, 2026 | 4.416M |
| August 25, 2026 | 4.450M |
| August 24, 2026 | 4.276M |
| August 21, 2026 | 4.376M |
| August 20, 2026 | 4.475M |
| August 19, 2026 | 4.674M |
| August 18, 2026 | 4.674M |
| August 17, 2026 | 4.748M |
| August 14, 2026 | 4.798M |
| August 13, 2026 | 4.947M |
| August 12, 2026 | 4.972M |
| August 11, 2026 | 4.685M |
| August 10, 2026 | 4.709M |
| August 07, 2026 | 4.733M |
| August 06, 2026 | 4.733M |
| August 05, 2026 | 4.804M |
| Date | Value |
|---|---|
| August 04, 2026 | 4.519M |
| August 03, 2026 | 4.531M |
| July 31, 2026 | 4.471M |
| July 30, 2026 | 4.471M |
| July 29, 2026 | 4.519M |
| July 28, 2026 | 4.519M |
| July 27, 2026 | 4.590M |
| July 24, 2026 | 4.614M |
| July 23, 2026 | 4.566M |
| July 22, 2026 | 4.638M |
| July 21, 2026 | 4.971M |
| July 20, 2026 | 4.828M |
| July 17, 2026 | 4.876M |
| July 16, 2026 | 4.923M |
| July 15, 2026 | 5.066M |
| July 14, 2026 | 4.971M |
| July 13, 2026 | 4.957M |
| July 10, 2026 | 4.876M |
| July 09, 2026 | 4.923M |
| July 08, 2026 | 4.923M |
| July 07, 2026 | 4.852M |
| July 06, 2026 | 5.114M |
| July 02, 2026 | 4.947M |
| July 01, 2026 | 5.137M |
| June 30, 2026 | 5.375M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 293.20M |
| Amgen, Inc. | 206.74B |
| Anika Therapeutics, Inc. | 280.71M |
| BioCryst Pharmaceuticals, Inc. | 2.119B |
| Imunon, Inc. | 6.765M |
Market Cap Related Metrics
| PS Ratio | 1114.08 |
| Price to Book Value | 5.720 |
| Price | 1.50 |
| Earnings Yield | -129.9% |